| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
31,350,000 |
| Market
Cap: |
16.03(M) |
| Last
Volume: |
15,038 |
Avg
Vol: |
14,996 |
| 52
Week Range: |
$0.2127 - $0.648 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
9,750 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,584 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
60,000 |
60,000 |
60,000 |
60,000 |
| Total Sell Value |
$950,777 |
$950,777 |
$950,777 |
$950,777 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
3 |
3 |
3 |
3 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Usman Nassim |
President and CEO |
• • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
74,375 |
74,375 |
|
- |
|
| Lawlor Augustine |
Director |
– • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,041,024 |
1,041,024 |
|
- |
|
| Himawan Jeff |
Director |
– • • |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,179,352 |
1,179,352 |
|
- |
|
| Madison Edwin |
Chief Scientific Officer |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
31,008 |
31,008 |
|
- |
|
| Payne Fletcher |
Chief Financial Officer |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
15,032 |
15,032 |
|
- |
|
| Hodges Mauri K |
VP, Fin. & Admin., CFO, Treas. |
• – – |
2014-12-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
41,259 |
|
- |
|
| Hodges Mauri K |
VP, Fin. & Admin., CFO, Treas. |
• – – |
2014-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,159 |
|
- |
|
| Dunton Alan W |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Desouza Errol B |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,333 |
|
- |
|
| Richard John P |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,333 |
|
- |
|
| Brown Julia R |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Blixt Charles A |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Toler Steven M. |
VP, Clin Pharm Sciences |
• – – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
46,000 |
|
- |
|
| Rock Patrick C. |
SVP, GC and Secretary |
• – – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
45,000 |
|
- |
|
| Hill Stephen A |
President & CEO |
• • – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
175,000 |
195,000 |
|
- |
|
| Musso Alan A |
SVP, Fin+Admin, CFO & Treas |
• – – |
2014-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
57,799 |
|
- |
|
141 Records found
|
|
Page 6 of 6 |
|
|
